AP2984A - An arteether injection for treatment of malaria - Google Patents

An arteether injection for treatment of malaria

Info

Publication number
AP2984A
AP2984A AP2011005552A AP2011005552A AP2984A AP 2984 A AP2984 A AP 2984A AP 2011005552 A AP2011005552 A AP 2011005552A AP 2011005552 A AP2011005552 A AP 2011005552A AP 2984 A AP2984 A AP 2984A
Authority
AP
ARIPO
Prior art keywords
arteether
malaria
injection
treatment
arteether injection
Prior art date
Application number
AP2011005552A
Other versions
AP2011005552A0 (en
Inventor
Rajani Gulabdas Patel
Arun Chimanial Shah
Jigar Hasmukhbhai Patel
Original Assignee
Lincoln Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lincoln Pharmaceutical Ltd filed Critical Lincoln Pharmaceutical Ltd
Publication of AP2011005552A0 publication Critical patent/AP2011005552A0/en
Application granted granted Critical
Publication of AP2984A publication Critical patent/AP2984A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2011005552A 2009-01-14 2009-12-30 An arteether injection for treatment of malaria AP2984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN97MU2009 2009-01-14
PCT/IN2009/000757 WO2010082219A2 (en) 2009-01-14 2009-12-30 An arteether injection for treatment of malaria

Publications (2)

Publication Number Publication Date
AP2011005552A0 AP2011005552A0 (en) 2011-02-28
AP2984A true AP2984A (en) 2014-09-30

Family

ID=42340178

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005552A AP2984A (en) 2009-01-14 2009-12-30 An arteether injection for treatment of malaria

Country Status (2)

Country Link
AP (1) AP2984A (en)
WO (1) WO2010082219A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020089942A2 (en) 2018-11-02 2020-05-07 Amaterasu Lifesciences Llp A liquid injectable composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044333A2 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Novel injectable antimalarial compositions of artemisinin
WO2004071509A1 (en) * 2003-02-12 2004-08-26 Nippon Chemiphar Co., Ltd. Oligodendrocyte differentiation promoters
CN1650854A (en) * 2004-12-08 2005-08-10 广州中生生物技术有限公司 Preparation technology of micro emulsion containing artemisic methyl ether (or artemisic ethyl ether or artemisic succinate)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393672A (en) * 2003-02-12 2013-11-20 乔治敦大学 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044333A2 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Novel injectable antimalarial compositions of artemisinin
WO2004071509A1 (en) * 2003-02-12 2004-08-26 Nippon Chemiphar Co., Ltd. Oligodendrocyte differentiation promoters
CN1650854A (en) * 2004-12-08 2005-08-10 广州中生生物技术有限公司 Preparation technology of micro emulsion containing artemisic methyl ether (or artemisic ethyl ether or artemisic succinate)

Also Published As

Publication number Publication date
WO2010082219A4 (en) 2010-12-23
WO2010082219A2 (en) 2010-07-22
AP2011005552A0 (en) 2011-02-28
WO2010082219A3 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
PL2512236T3 (en) Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
IL215516A0 (en) Emulsions of perfluorocarbons
GB0918145D0 (en) Injector apparatus
GB0915515D0 (en) Treatment of vasculoproliferative conditions
GB201207472D0 (en) Novel parasite therapy
SMT202100713T1 (en) Infusion of drugs
IL215865B (en) Formulation of meloxicam
IL206491A0 (en) Treatment of produce
ZA201109514B (en) Method of drug delivery
ZA201003844B (en) Delivery of functional compounds
IL215377A0 (en) Method of genotyping
IL216119A0 (en) Method of decreasing ubiquitylated protein levels
IL213955A0 (en) Method for improved bioactivation of medications
ZA201300083B (en) New drug combinations for the treatment of malaria
EG26793A (en) Medical injector
GB0908101D0 (en) Treatment of stress
PL2493305T3 (en) 2-aminoindole compounds and methods for the treatment of malaria
AP2984A (en) An arteether injection for treatment of malaria
EP2424539A4 (en) Method of treatment of depression
EP2404891A4 (en) Preparation method of acylbenzenes
TWM370404U (en) Structure of compound massage set
GB0900114D0 (en) An improved method of coving
GB0904164D0 (en) Method of treatment
GB0909807D0 (en) Method of treatment
GB0921823D0 (en) Method of treatment